Ieq Capital LLC Acquires New Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Ieq Capital LLC acquired a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the fourth quarter, Holdings Channel.com reports. The fund acquired 3,065 shares of the company’s stock, valued at approximately $239,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in Prestige Consumer Healthcare by 3.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after acquiring an additional 49,331 shares in the last quarter. Geode Capital Management LLC grew its position in Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after acquiring an additional 50,961 shares in the last quarter. Congress Asset Management Co. grew its position in Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after acquiring an additional 43,619 shares in the last quarter. Boston Trust Walden Corp grew its position in Prestige Consumer Healthcare by 43.5% in the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock worth $64,942,000 after acquiring an additional 252,089 shares in the last quarter. Finally, Eagle Asset Management Inc. grew its position in Prestige Consumer Healthcare by 0.7% in the third quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company’s stock worth $31,328,000 after acquiring an additional 3,227 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

NYSE:PBH opened at $84.61 on Friday. The stock has a market cap of $4.19 billion, a P/E ratio of 19.81, a PEG ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $88.36. The company has a fifty day moving average price of $80.04 and a 200 day moving average price of $77.14. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on PBH. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Sidoti cut shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. Canaccord Genuity Group boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Finally, DA Davidson upped their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.